Medicine and Dentistry
Pancreas Cancer
100%
Neoplasm
76%
Malignant Neoplasm
45%
Pancreas Adenocarcinoma
36%
Colorectal Cancer
32%
Intraductal Papillary Mucinous Tumor
32%
Adenocarcinoma
29%
Next Generation Sequencing
28%
Biological Marker
21%
Gene Mutation
21%
Microsatellite Instability
19%
DNA Mismatch Repair
17%
Prostate Cancer
17%
Cancer Cell
15%
Disease
14%
Metastatic Carcinoma
13%
Cell Line
11%
Organoid
11%
Personalized Medicine
11%
Polymerase Chain Reaction
11%
Castration Resistant Prostate Cancer
10%
Pancreatic Cysts
10%
Somatic Mutation
10%
Nodular Melanoma
9%
Circulating Tumor DNA
9%
Polymerase Chain Reaction
9%
Somatics
9%
Acute Myeloid Leukemia
8%
Human Immunodeficiency Virus
8%
Pancreas Cyst
8%
Overall Survival
8%
Targeted Therapy
8%
Pancreas Tumor
8%
Epidermal Growth Factor Receptor
8%
Enzalutamide
8%
Drug Resistance
8%
Clinical Trial
7%
Fine-Needle Aspiration
7%
Surgery
7%
Lung Cancer
7%
Carcinoma
7%
Mitogen-Activated Protein Kinase
7%
Dysplasia
7%
Resistance Mutation
7%
Primary Tumor
7%
Pancreatic Duct
7%
Mutagenic Agent
7%
Codon
6%
Recurrent Disease
6%
Adenoma
6%
Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
51%
KRAS
37%
Cancer Cell
37%
Microsatellite Instability
33%
Genetics
32%
Somatic Mutation
26%
Gene Mutation
24%
Pyrosequencing
23%
Allele
23%
Colon
23%
Codon
20%
Epidermal Growth Factor Receptor
19%
Microsatellite DNA
18%
DNA Mismatch Repair
18%
Germ Cell
17%
Germline
17%
Prevalence
16%
Carcinogenesis
16%
Methylation
15%
Whole Genome Sequencing
13%
Single-Nucleotide Polymorphism
13%
Gene Frequency
12%
Polymerase Chain Reaction
12%
Genotyping
10%
Gene Expression
10%
Exon
10%
Tumor Marker
10%
DNA Repair
9%
Overall Survival
9%
Loss of Heterozygosity
9%
Point Mutation
9%
Microarrays
9%
Mouse
9%
RNA
9%
Signal Transduction
9%
Circulating Tumor DNA
9%
Wild Type
9%
Mitogen-Activated Protein Kinase
9%
Enzyme
9%
Dysplasia
8%
Promoter Region
8%
ARID1A
8%
DNA Methylation
8%
Genome Instability
7%
Epigenetics
7%
Tumor Suppressor Gene
7%
DNA Sequence
7%
Indel
7%
Transcriptomics
7%
Small Molecule
7%
Keyphrases
Pancreatic Cancer
58%
Tumor
44%
Colorectal Cancer
28%
Microsatellite Instability-high (MSI-H)
19%
Pancreatic Ductal Adenocarcinoma
19%
Mismatch Repair
18%
KRAS mutation
17%
Pancreatic Adenocarcinoma
16%
Next-generation Sequencing
16%
BRAF mutation
16%
Somatic mutation
15%
Intraductal Papillary mucinous Neoplasm
14%
Gene mutation
13%
BRAF V600E mutation
12%
Cancer Cells
11%
Familial Pancreatic Cancer
10%
Melanoma
10%
Esophageal Adenocarcinoma
10%
Clinical Validation
9%
Pyrosequencing
9%
Circulating Tumor DNA (ctDNA)
9%
AR-V7
9%
Neoplasms
8%
Mutational Profiling
8%
Adenocarcinoma
8%
Pancreatic Cyst
7%
Metastasis
7%
Tumor Subtype
7%
Isocitrate Dehydrogenase 1 (IDH1)
7%
Colon Cancer Cells
7%
Genotype
7%
Pancreas
7%
Recurrent mutation
7%
Adenocarcinoma Cells
7%
Driver mutations
7%
Mutation Detection
7%
Human Immunodeficiency Virus Type 1 (HIV-1)
7%
K103N
7%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
6%
Whole Exome Sequencing
6%
Genetic Modification
6%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
6%
Apoptosis
6%
KRAS2
6%
Dysregulation
6%
FLT3 Internal Tandem Duplication
6%
Superoxide Dismutase 2 (SOD2)
6%
MutY
6%
Resistance mutations
6%
Nevirapine Resistance
6%
